TDH Activators

L-threonine dehydrogenase (TDH) is an enzyme that catalyzes the NAD+-dependent conversion of threonine to aminoacetone and glycine in the presence of zinc ions. This reaction is part of the amino acid catabolism pathway, specifically involved in the degradation of threonine to glycine. The byproduct aminoacetone can subsequently be converted into other metabolites, which can enter various metabolic pathways including the synthesis of acetyl-CoA, an important molecule in energy production and lipid metabolism.In humans, the TDH gene is located on chromosome 8 and encodes the TDH protein. The activity of TDH is relatively low in human tissues, and it is not considered the main pathway for threonine catabolism in humans. Instead, threonine is primarily catabolized by the enzyme threonine aldolase. However, in certain organisms, like bacteria and yeast, TDH plays a significant role in threonine metabolism.

Structurally, TDH is characterized by the presence of an oxidoreductase domain, which binds to NAD+ and contains the active site for the dehydrogenase reaction. It also has a binding site for zinc ions, which are essential for its catalytic activity.Mutations or alterations in TDH activity could potentially lead to metabolic imbalances. For example, in organisms where TDH is a primary route for threonine degradation, disruptions in TDH function could lead to threonine accumulation or deficiency in downstream metabolites, affecting metabolic homeostasis.The study of TDH, like that of many enzymes in metabolic pathways, provides insights into basic biological processes and has potential applications in biotechnology. For instance, manipulating TDH activity in microorganisms can be used to control the production of metabolites found in threonine catabolism, which may have industrial.